| Property | Value |
|---|
|
?:abstract
|
-
• Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS) coronavirus 2 has affected 188 countries worldwide with a global death toll of over half a million; • Patients with valvular heart disease are also at an increased risk of adverse outcomes from coronavirus disease-2019; • Prognosis of patients with the combination of COVID 19 and severe valvular heart disease is poor; • This is the first reported case of MitraClip insertion in a patient with severe COVID 19 infection. This procedure assisted in the patient’s recovery relieving his cardiac burden and pulmonary edema enabling him to undergo colorectal surgery.
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:doi
|
|
|
?:doi
|
-
10.1016/j.case.2020.10.004
|
|
?:journal
|
|
|
?:license
|
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/adeb4e958d6ad4720c591db77fabf62f98dfcbb3.json
|
|
?:pmcid
|
|
|
?:pmid
|
|
|
?:pmid
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:sha_id
|
|
|
?:source
|
|
|
?:title
|
-
Mitraclip insertion to hasten recovery from severe COVID-19 disease
|
|
?:type
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}